靶向生长激素释放激素受体治疗急性髓系白血病的新方法
研究检测了生长激素释放激素受体(GHRH-R)在4株人急性髓系白血病(AML)细胞系中的表达,其中K-562、THP-1和KG-1a三株表达该受体,GHRH拮抗剂MIA-602在体外抑制这三株细胞增殖并上调促凋亡基因、抑制Akt信号,在荷瘤小鼠中大幅减少肿瘤生长,9例AML患者样本均证实GHRH-R表达。
要点
- 4株人AML细胞系中3株(K-562、THP-1、KG-1a)表达GHRH-R。
- MIA-602在体外抑制这三株细胞增殖,伴促凋亡基因上调和Akt信号抑制。
- MIA-602使荷人AML细胞系异种移植瘤小鼠的肿瘤生长大幅减少;9例AML患者样本均表达GHRH-R。
核心结论
- 这些发现为这一恶性肿瘤提供了新的治疗途径,并提示GHRH-R信号可能在AML病理中发挥作用。
研究设计与样本
- 研究检测了4株人AML细胞系及9例AML患者样本中GHRH-R的表达,并在体外和荷人AML细胞系异种移植瘤小鼠中评估GHRH拮抗剂MIA-602的作用。
主要发现
- 4株人AML细胞系中K-562、THP-1和KG-1a三株存在GHRH-R,与MIA-602孵育后这三株细胞体外增殖受到显著抑制。
- 该增殖抑制与白血病细胞中促凋亡基因上调和Akt信号抑制相关。
- 对荷这些人类AML细胞系异种移植瘤的小鼠给予MIA-602治疗,肿瘤生长大幅减少。
- 9例AML患者样本中GHRH-R表达均得到证实。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Growth hormone-releasing hormone (GHRH) is secreted by the hypothalamus and acts on the pituitary gland to stimulate the release of growth hormone (GH). GHRH can also be produced by human cancers, in which it functions as an autocrine/paracrine growth factor. We have previously shown that synthetic antagonistic analogues of GHRH are able to successfully suppress the growth of 60 different human cancer cell lines representing over 20 cancers. Nevertheless, the expression of GHRH and its receptors in leukaemias has never been examined. Our study demonstrates the presence of GHRH receptor (GHRH-R) on 3 of 4 human acute myeloid leukaemia (AML) cell lines-K-562, THP-1, and KG-1a-and significant inhibition of proliferation of these three cell lines in vitro following incubation with the GHRH antagonist MIA-602. We further show that this inhibition of proliferation is associated with the upregulation of pro-apoptotic genes and inhibition of Akt signalling in leukaemic cells. Treatment with MIA-602 of mice bearing xenografts of these human AML cell lines drastically reduced tumour growth. The expression of GHRH-R was further confirmed in 9 of 9 samples from patients with AML. These findings offer a new therapeutic approach to this malignancy and suggest a possible role of GHRH-R signalling in the pathology of AML.
引用
- Jimenez JJ, DelCanto GM, Popovics P, et al. A new approach to the treatment of acute myeloid leukaemia targeting the receptor for growth hormone-releasing hormone. Br J Haematol. 2018. PMID: 29663325. doi:10.1111/bjh.15207
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。